SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000950135-04-005271
Filing Date
2004-11-10
Accepted
2004-11-10 15:22:07
Documents
4
Period of Report
2004-09-30

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS, INC. b51855qae10vqza.htm 10-Q/A 16354
2 EX-31.1 SECTION 302 CERTIFICATION OF C.E.O. b51855qaexv31w1.txt EX-31.1 3499
3 EX-31.2 SECTION 302 CERTIFICATION OF C.F.O. b51855qaexv31w2.txt EX-31.2 3442
4 EX-32.1 SECTION 906 CERTIFICATION b51855qaexv32w1.txt EX-32.1 1861
  Complete submission text file 0000950135-04-005271.txt   27140
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-29089 | Film No.: 041132919
SIC: 2836 Biological Products, (No Diagnostic Substances)